Durable responses to anti-PD1 and anti-CTLA4 in a preclinical model of melanoma displaying key immunotherapy response biomarkers

Search results

• Finished

  Determinants of response to immune checkpoint inhibitors in melanoma

  Rizos, H., Long, G., Menzies, A. M., Yang, J., Carlino, M., Kefford, R., Scolyer, R., MQRES, M., MQRES 3 (International), M. 3. & De St Groth, B. F.

  1/01/17 → 31/12/20

  Project: Research

• Acquired resistance to PD1 inhibition in melanoma

  Rizos, H., Carlino, M., Kefford, R., Zhang, X. D., Menzies, A. M., Long, G., McGuire, H., Yang, J., Scolyer, R. & De St Groth, B. F.

  1/01/17 → 31/12/21

  Project: Research

• Manipulating oncogene addiction and immunity in the treatment of melanoma

  Rizos, H.

  1/01/16 → 31/12/20

  Project: Research